Regional variations in the prevalence and misdiagnosis of air flow obstruction in China: baseline results from a prospective cohort of the China Kadoorie Biobank (CKB)
暂无分享,去创建一个
R. Collins | R. Peto | Junshi Chen | Yu Guo | Liming Li | Margaret Smith | Z. Bian | K. Davis | O. Kurmi | Jian Wang | G. Xu | Jingxin Qin | G. Zhou | M. Augustyn | Yabin Han | Zhenming Chen
[1] V. Barger. International steering committee , 2020, 2012 14th International Conference on Megagauss Magnetic Field Generation and Related Topics (MEGAGAUSS).
[2] Q. Yi,et al. Association of chronic obstructive pulmonary disease with coronary artery disease , 2013, Chinese medical journal.
[3] P. Calverley,et al. Bronchodilator reversibility in chronic obstructive pulmonary disease: use and limitations. , 2013, The Lancet. Respiratory medicine.
[4] S. Hurd,et al. The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD) – why and what? , 2012, The clinical respiratory journal.
[5] S. Stanojevic,et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations , 2012, European Respiratory Journal.
[6] T. To,et al. Pulmonary function testing in the diagnosis of asthma: a population study. , 2012, Chest.
[7] R. Collins,et al. China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. , 2011, International journal of epidemiology.
[8] J. Walters,et al. Factors associated with misdiagnosis of COPD in primary care. , 2011, Primary care respiratory journal : journal of the General Practice Airways Group.
[9] N. Zhong,et al. Asymptomatic patients of chronic obstructive pulmonary disease in China. , 2010, Chinese medical journal.
[10] J. Soriano,et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities , 2009, Thorax.
[11] A. Buist,et al. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study , 2009, European Respiratory Journal.
[12] A. Buist,et al. Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[13] Shengming Liu,et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. , 2007, American journal of respiratory and critical care medicine.
[14] D. Mannino,et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.
[15] D. Mannino,et al. Global burden of COPD: risk factors, prevalence, and future trends , 2007, The Lancet.
[16] C. Mathers,et al. Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.
[17] R. West,et al. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample , 2006, Thorax.
[18] D. Mannino,et al. Global burden of COPD: systematic review and meta-analysis , 2006, European Respiratory Journal.
[19] R. Collins,et al. Cohort profile: the Kadoorie Study of Chronic Disease in China (KSCDC). , 2005, International journal of epidemiology.
[20] J. Hankinson,et al. Interpretative strategies for lung function tests , 2005, European Respiratory Journal.
[21] Fei Xu,et al. Prevalence of physician-diagnosed COPD and its association with smoking among urban and rural residents in regional mainland China. , 2005, Chest.
[22] G. Viegi,et al. Standardisation of the measurement of lung volumes , 2005, European Respiratory Journal.
[23] J. Hankinson,et al. General considerations for lung function testing , 2005, European Respiratory Journal.
[24] M. Chan-yeung,et al. The prevalence of asthma and asthma-like symptoms among adults in rural Beijing, China , 2002, European Respiratory Journal.
[25] John L. Hankinson,et al. Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.
[26] P. Enright,et al. Interpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patients. , 2011, Chest.
[27] F. Martinez,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.